Caroline Baumal
Chief Tech/Sci/R&D Officer chez APELLIS PHARMACEUTICALS, INC.
Fortune : 3 M $ au 30/04/2024
Profil
Caroline Baumal is currently the Chief Medical Officer at Apellis Pharmaceuticals, Inc. and a Professor at New England Eye Center.
She holds a doctorate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/01/2024 | 58 376 ( 0,05% ) | 3 M $ | 30/04/2024 |
Postes actifs de Caroline Baumal
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03/01/2023 |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Caroline Baumal
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Health Services |
